<H2> </H2> |
<H3> Higher performance with AI </H3> |
<H3> Applying AI to drug design is recognised as one of the ultimate scientific challenges </H3> |
<H3> Smarter design decisions with AI </H3> |
<H3> Higher performance with AI </H3> |
<H3> Applying AI to drug design is recognised as one of the ultimate scientific challenges </H3> |
<H3> Smarter design decisions with AI </H3> |
<H3> Higher performance with AI </H3> |
<H3> Revolutionising drug discovery </H3> |
<H3> Better by design </H3> |
<H3> Faster by design </H3> |
<H3> Precision design </H3> |
<H3> Revolutionising drug discovery </H3> |
<H3> Faster by design </H3> |
<H3> Better by design </H3> |
<H3> Better by design </H3> |
<H3> Faster by design </H3> |
<H3> Precision design </H3> |
<H3> Revolutionising drug discovery </H3> |
<H3> Faster by design </H3> |
<H3> Better by design </H3> |
<H3> Better by design </H3> |
<H3> Faster by design </H3> |
<H3> Precision design </H3> |
<H3> Patient First AI </H3> |
<H4> Better drugs faster </H4> |
<H4> Our pipeline </H4> |
<H4> World first </H4> |
<H4> Clinical Impact </H4> |
<H4> Our pipeline </H4> |
<H4> World first </H4> |
<H4> Clinical Impact </H4> |
<H4> Our pipeline </H4> |
<H4> Drug discovery is a learning challenge </H4> |
<H4> Careers at Exscientia </H4> |
<H5> </H5> |
<H5> Our carefully engineered systems combine advanced AI design with exacting experimental validation to rapidly progress a pipeline of drug discovery assets. </H5> |
<H5> Exscientia are spearheading the drug discovery revolution with the first AI-Designed molecules to reach clinic trials. </H5> |
<H5> Ground-breaking clinical impact. Our Patient-first AI platform has already demonstrated improved treatment outcomes in a prospective interventional study </H5> |
<H5> Our carefully engineered systems combine advanced AI design with exacting experimental validation to rapidly progress a pipeline of drug discovery assets. </H5> |
<H5> Exscientia are spearheading the drug discovery revolution with the first AI-Designed molecules to reach clinic trials. </H5> |
<H5> Ground-breaking clinical impact. Our Patient-first AI platform has already demonstrated improved treatment outcomes in a prospective interventional study </H5> |
<H5> Our carefully engineered systems combine advanced AI design with exacting experimental validation to rapidly progress a pipeline of drug discovery assets. </H5> |
<H5> Faster by design </H5> |
<H5> Better by design </H5> |
<H5> Company </H5> |
<H5> About us </H5> |
<H5> Patient-first AI </H5> |
<H5> Social </H5> |
<H6> Efficient </H6> |
<H6> Quality </H6> |
<H6> Unprecedented speed </H6> |
<H6> Navigating Chemical Space </H6> |
<H6> Learning efficiently with AI </H6> |
<H6> Exscientia AI </H6> |
<H6> Efficient </H6> |
<H6> Quality </H6> |
<H6> Unprecedented speed </H6> |
<H6> Navigating Chemical Space </H6> |
<H6> Learning efficiently with AI </H6> |
<H6> Exscientia AI </H6> |
<H6> Efficient </H6> |
<H6> Quality </H6> |
<H6> Unprecedented speed </H6> |
Social
Social Data
Cost and overhead previously rendered this semi-public form of communication unfeasible.
But advances in social networking technology from 2004-2010 has made broader concepts of sharing possible.